Long-term persistence in use of statin therapy in elderly patients.

By J. Benner, Robert J. Glynn, H. Mogun, P. Neumann, M. Weinstein, J. Avorn. Journal of the American Medical Association (JAMA), 2002

1,283 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Statistics and Probability, Surgery

View Paper: https://www.semanticscholar.org/paper/1db1540bb08aa2118651e8712a049d68876b8e55

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. Sebastian Schneeweiss
2. J. Avorn
3. S. Daniels
4. Katherine P. Liao
5. Peter C. Austin

In Statistics and Probability

1. Sebastian Schneeweiss
2. J. Avorn
3. Katherine P. Liao
4. Peter C. Austin

In Surgery

1. R. Barnard
2. Christian K. Roberts
3. S. Grundy
4. A. Hevener

Citations in the corpus

• National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. (2015, background): “Approximately 25– 50% of patients discontinue statins within 1 year of treatment initiation, and persistence of use further decreases over time.(774,775) Results from studies have been mixed, but some have found that predictors of statin nonadherence include younger patient age, female sex, lower in”
• Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training (2013, positive): “Avorn and colleagues (34) noted that patients 65 years of age or more failed to fill prescriptions for lipid-lowering drugs for about 40% of the study year and that approximately 45% were adherent to statin medications after 6 months (60).”
• A review of uses of health care utilization databases for epidemiologic research on therapeutics. (2005, methodology): “For example, research using Medicare and Medicaid database studies showed that adherence to statin therapy among poor elderly patients was below 60% (proportion of days covered) after 6 months and continued to decline afterward [7].”
• Factors affecting therapeutic compliance: A review from the patient’s perspective (2008, neutral): “…Hispanics and other minorities were found to have comparatively poor compliance (Schweizer et al 1990; Monane et al 1996; Leggat et al 1998; Benner et al 2002; Apter et al 2003; Opolka et al 2003; Spikmans et al 2003; Butterworth et al 2004; Kaplan et al 2004; Dominick et al 2005).”